Physician profile
Puneet Gupta
NPI 1427498674
$2,203.64
in general payments reported to CMS, 2019-2025
26 companies · $470 in 2025
The $470 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $93.21 · 2021: $115 · 2022: $323 · 2023: $416 · 2024: $466 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,352.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $409.14 | 2024-2025 | |
| Abbott Laboratories | $303.83 | 2019-2023 | Jot Dx |
| Janssen Pharmaceuticals, INC | $238.18 | 2019-2024 | Xarelto |
| Amgen INC. | $183.60 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $182.08 | 2021-2024 | Lifevest |
| Terumo Medical Corporation | $119.28 | 2021-2022 | |
| Pfizer INC. | $95.28 | 2022-2025 | |
| Atricure, INC. | $89.32 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| E.R. Squibb & Sons, L.L.C. | $68.12 | 2023-2024 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $57.54 | 2023-2025 | Brilinta, Tezspire |
| Cvrx, INC. | $48.10 | 2024 | Barostim Neo System |
| Philips North America LLC | $43.36 | 2023 | |
| Baxter Healthcare | $38.01 | 2022-2024 | Hillrom - Carnation Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $34.95 | 2022-2024 | |
| Edwards Lifesciences Corporation | $33.12 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $33.04 | 2022 | |
| Merck Sharp & Dohme LLC | $32.03 | 2023 | Keytruda |
| Ethicon US, LLC | $29.59 | 2024 | Surgicel Nu-Knit, Vistaseal, Ethicon |
| Inspire Medical Systems, INC. | $28.65 | 2023-2024 | Inspire |
| Angiodynamics, INC. | $24.29 | 2023 | Auryon Laser System 100-120 Vac |
| Grifols USA, LLC | $21.04 | 2025 | Prolastin-C Liquid |
| Alnylam Pharmaceuticals INC. | $19.67 | 2024 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $19.03 | 2025 | |
| United Therapeutics Corporation | $18.43 | 2023 | Tyvaso |
| Siemens Medical Solutions USA, INC. | $17.21 | 2024 | Cios Spin |
| Shockwave Medical, INC | $16.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Puneet Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.